Iteos Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

iTeos Therapeutics

10/08/2022 21:30

* Iteos Therapeutics Inc  ITOS.OQ  reported quarterly
adjusted
earnings of 15 cents​​ per share for the quarter ended in June.
The mean expectation of five analysts for the quarter was
for earnings of $1.20 per share.
    * Revenue was $41.72 million​; analysts expected $85.56
million. 
    * Iteos Therapeutics Inc's reported EPS for the quarter was
15
cents​.
    * The mean earnings estimate of analysts had risen by
about 63% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Iteos Therapeutics Inc shares had risen by 27.0% this
quarter and lost 43.8% so far this year.
    * The company reported quarterly net income of $5.63
million.
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $48.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 08:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      1.20           0.15           Missed
 Mar. 31 2022      0.80           1.82           Beat
 Dec. 31 2021      1.28           4.89           Beat
 Sep. 30 2021      4.95           1.86           Missed